Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sunscreen call for data

This article was originally published in The Tan Sheet

Executive Summary

FDA is seeking submissions of safety and efficacy data for diethylhexyl butamido triazone, up to 3%, as a sunscreen single active ingredient and in combination with other sunscreen active ingredients, according to a Federal Register notice July 26. The agency has reviewed a Time & Extent Application for the ingredient submitted in 2005 by 3V Inc. and has determined that it is eligible for inclusion in an OTC monograph. FDA notes, however, that the TEA did not include an official or proposed U.S. Pharmacopoeia National Formulary (USP-NF) drug monograph for diethylhexyl butamido triazone, and an official or proposed USP-NF must be included as part of the safety and effectiveness data for the ingredient. The deadline for submissions is Oct. 26...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099619

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel